<--- Back to Details
First PageDocument Content
Clinical research / Research / Pharmaceuticals policy / Pharmaceutical industry / Bioavailability / Bioequivalence / Regulatory requirement / Abbreviated New Drug Application / Clinical trial / Pharmaceutical sciences / Pharmacology / Pharmacokinetics
Date: 2013-06-24 11:52:38
Clinical research
Research
Pharmaceuticals policy
Pharmaceutical industry
Bioavailability
Bioequivalence
Regulatory requirement
Abbreviated New Drug Application
Clinical trial
Pharmaceutical sciences
Pharmacology
Pharmacokinetics

Guidance Document: Conduct and Analysis of Comparative Bioavailability Studies

Add to Reading List

Source URL: www.hc-sc.gc.ca

Download Document from Source Website

File Size: 181,42 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvUb - View Document

PDF Document

DocID: 1xc8R - View Document

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

DocID: 1vqsj - View Document

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

DocID: 1vlJU - View Document

Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

DocID: 1vk1K - View Document